Endometrial Carcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours [Phase 1, Phase 2]
Phase 1/2 trial results of NUC-3373 in combination with other agents in patients with advanced solid tumors; study status terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer [Phase 3]
A Phase 3 trial evaluating adding bevacizumab to carboplatin-paclitaxel and pembrolizumab for pMMR TP53-mutated advanced or recurrent endome…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: FOG-001 in Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
FOG-001 is being studied in a Phase 1/2 trial across multiple locally advanced or metastatic solid tumors and is currently recruiting; indic…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial [Phase 1]
This is an early-stage (Phase 1) clinical trial evaluating the combination of DS-8201a (trastuzumab deruxtecan) and AZD6738 (camonsertib) fo…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. [Phase 3]
Phase 3 clinical trial evaluating sentinel lymph node policy in early-stage endometrial carcinoma at intermediate/high risk of recurrence; c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain [Phase 4]
A Phase 4 trial update describes using low-dose aspirin to reduce inflammation and prevent endometrial cancer in postmenopausal women with n…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Screening and Staging of Benign vs Malignant Pelvic Abnormalities
A Mayo Clinic study is currently recruiting to evaluate screening and staging of benign versus malignant pelvic abnormalities, including end…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma [Phase 2]
Clinical trial update for sacituzumab govitecan (IMMU-132) in endometrial carcinoma, a Phase 2 study currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma [Phase 2]
A Phase II, two-arm trial evaluating everolimus and letrozole with or without ribociclib (Lee011) in patients with advanced or recurrent end…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer [Phase 2]
Phase 2 clinical trial comparing megestrol acetate alone versus megestrol acetate plus metformin to prevent endometrial cancer; current stat…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Pilot Window of Opportunity Trial (POET) [Phase 2]
This report provides an update on the Phase 2 Pilot Window of Opportunity Trial (POET) led by the University of Oklahoma, currently listed a…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: GYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial Cancer [EARLY_Phase 1]
An EARLY Phase 1 clinical trial evaluating GYNORYLAQ-VLINIVAL, a Ψ-guided personalized neoantigen peptide vaccine, for high-risk endometrial…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy [Phase 2]
Phase 2 clinical trial evaluating Megestrol Acetate with or without Pterostilbene in patients with endometrial cancer undergoing hysterectom…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Study of GV20-0251 in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
GV20 Therapeutics is evaluating GV20-0251 in a Phase 1/2 trial for adults with various solid tumors, and the study is currently recruiting. …
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
This ClinicalTrials.gov entry describes a study examining pelvic floor dysfunction and quality of life in survivors of uterine cancers, incl…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma [Phase 2]
Phase II study of Futibatinib in combination with Pembrolizumab for metastatic microsatellite-stable endometrial carcinoma was terminated; r…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer
A clinical trial is investigating patient-derived tumor-like cell clusters as a predictor of progesterone sensitivity in patients with early…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia [Phase 2]
Phase 2 clinical trial evaluating a progesterone-based therapeutic regimen combined with statins for young women with early endometrial carc…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy
A clinical trial update examining changes in pelvic health, sexual function, and quality of life in women with pelvic cancers undergoing rad…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies [Phase 1, Phase 2]
This document reports a Phase 1/Phase 2 clinical trial evaluating GV20-0251 as monotherapy and in combination with pembrolizumab in several …
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of Nivolumab in Selected Uterine Cancer Patients [Phase 2]
Phase 2 study of Nivolumab in selected uterine cancers has completed enrollment and posted results in 2024.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) [Phase 3]
Phase 3 trial comparing pembrolizumab plus lenvatinib to chemotherapy in endometrial cancer has completed with results posted in October 202…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO)
An ongoing Assiut University study investigating clinicopathological aspects of endometrial carcinoma in the context of old and new FIGO sta…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives
A completed clinical trial update examining factors influencing cascade genetic testing among women with hereditary gynecologic cancers and …
-
CLINICAL_TRIALS research · 2024-07-11Clinical Trial Update: Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia [Phase 2]
Phase 2 clinical trial evaluating medroxyprogesterone acetate plus atorvastatin in young women with atypical endometrial hyperplasia or earl…